Related Experiment Videos
Establishment of an expression cloning system for CD4+ T cell epitopes
1Division of Immunogenetics, Department of Neuroscience and Immunology, Kumamoto University Graduate School of Medical Sciences, Honjo 2-2-1, Kumamoto, 860-0811, Japan.
Biochemical and Biophysical Research Communications
|June 21, 2001
Summary
Researchers developed a novel expression cloning system to identify CD4+ T cell epitopes. This system successfully identified a cross-reactive epitope for a diabetes-associated T cell clone, demonstrating its broad applicability.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- The invariant chain (Ii) is crucial for MHC class II molecule presentation.
- The pCI vector allows substitution of the CLIP region with antigenic peptides.
- Identifying CD4+ T cell epitopes is vital for understanding immune responses and developing therapies.
Purpose of the Study:
- To develop and validate a new expression cloning system for identifying CD4+ T cell epitopes.
- To isolate novel cross-reactive epitopes using a randomized peptide library.
- To assess the utility of the system for detecting unknown T cell epitopes.
Main Methods:
- Utilized a modified invariant chain (Ii) expression vector (pCI) for epitope presentation.
- Constructed an epitope-presenting library by inserting randomized 13-mer peptides.
- Loaded peptides onto HLA class II molecules coexpressed in COS-7 cells.
- Screened the library using a T cell clone from a patient with insulin-dependent diabetes mellitus.
Main Results:
- Successfully identified a novel epitope (PVQLSNQWHVVGATF) recognized by a GAD65-autoreactive T cell clone.
- The newly identified epitope showed cross-reactivity and comparable T cell stimulation to the original GAD65 epitope (p116-128).
- The identified epitope sequence was significantly different from the original GAD65 epitope.
Conclusions:
- The developed expression cloning system is effective for identifying CD4+ T cell epitopes, including cross-reactive ones.
- The system can identify epitopes for T cells with known specificities and potentially for those with unknown epitopes.
- This approach holds promise for advancing research in autoimmune diseases and T cell-mediated immunity.